Doggrell, Sheila A <br/><br/>
Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?  [electronic resource] 

 -  Expert opinion on investigational drugs  Feb 2004 
 - 161-3 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1354-3784 
<br/><br/><label>Standard No.: </label>10.1517/13543784.13.2.161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--pharmacology<br/>Aged<br/>Azathioprine--pharmacology<br/>Cholesterol--blood<br/>Cholesterol, LDL--blood<br/>Clinical Trials as Topic<br/>Creatinine--blood<br/>Cyclosporins--administration & dosage<br/>Drug Therapy, Combination<br/>Everolimus<br/>Graft Rejection--complications<br/>Heart Transplantation--methods<br/>Humans<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Peripheral Vascular Diseases--complications<br/>Sirolimus--adverse effects<br/>Transplantation, Homologous--adverse effects